On August 18, 2020, iRhythm Technologies, Inc., a leading digital health care solutions company focused on the advancement of cardiac care, announced the pricing of its underwritten public offering of 1,093,167 shares of its common stock at a public offering price of $175 per share before deducting underwriting discounts and commissions. All of the shares are being offered for sale by iRhythm Technologies.

In addition, iRhythm Technologies has granted the underwriters a 30-day option to purchase up to an additional 163,975 shares of its common stock at the public offering price, less underwriting discounts and commissions.

The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by iRhythm Technologies, are expected to be $191.3 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on August 21, 2020, subject to customary closing conditions.

The Wilson Sonsini Goodrich & Rosati team that represented iRhythm in the transaction includes Jesse Schumaker and Philip Oettinger.

For more information, please see iRhythm Technologies' press release.